Global Veterinary Products Market Size By Type (Medicines, Vaccine), By Application (Companion Animals, Livestock Animals), By Region, And Segment Forecasts, 2023 to 2032

The Global Veterinary Products Market was valued at USD 45.6 billion in 2023 and is projected to reach USD 76.4 billion by 2031, growing at a CAGR of 6.6% during the forecast period (2023–2031). The market is expanding rapidly due to increasing pet adoption, rising awareness of animal health, and the growing demand for livestock-derived food products. The development of innovative veterinary pharmaceuticals and biologics, combined with enhanced distribution networks, has further strengthened market growth globally.

Drivers:

1. Surge in Pet Ownership and Companion Animal Spending:

Growing human-animal bonding has resulted in higher spending on pet healthcare and wellness. Owners are increasingly investing in preventive and therapeutic treatments, vaccines, and nutritional supplements, boosting the demand for veterinary products.

2. Demand for Animal-Derived Food Products:

Rising global population and increasing protein consumption are driving the demand for meat, milk, and eggs, encouraging livestock owners to use veterinary products for disease prevention and productivity enhancement.

3. Advancements in Veterinary Medicine:

Innovations in vaccine technologies, diagnostics, and biologics are significantly enhancing treatment outcomes and creating opportunities for advanced veterinary product offerings.

Restraints:

1. Stringent Regulatory Framework:

The veterinary industry is subject to rigorous approval processes for new drugs and vaccines, which can delay product launches and increase R&D costs.

2. High Costs of Veterinary Care:

The cost of veterinary services and medications can be a barrier, particularly in developing regions, limiting accessibility for both pet owners and livestock farmers.

Opportunity:

1. Expansion in Emerging Markets:

Regions such as Asia-Pacific and Latin America offer lucrative growth prospects due to rising incomes, increasing awareness of animal welfare, and government initiatives supporting veterinary infrastructure.

2. Growth in E-commerce and Telemedicine:

The adoption of online platforms for purchasing veterinary products and telemedicine services has expanded access to care and facilitated market penetration, especially in remote areas.

Market by System Type Insights:

Based on product type, the Pharmaceuticals segment held the largest market share in 2023. This segment includes antiparasitics, anti-infectives, and anti-inflammatory drugs essential for treating various animal diseases. The Biologics segment, including vaccines and immunomodulators, is anticipated to register the highest growth rate during the forecast period due to increased immunization efforts for pets and livestock.

Market by End-use Insights:

By end-use, the Livestock segment dominated the market in 2023, driven by the need to prevent and control diseases that affect the productivity and quality of meat and dairy products. The Companion Animals segment is expected to grow rapidly, supported by rising pet ownership, increasing veterinary visits, and the trend toward pet humanization.

Market by Regional Insights:

North America held the largest market share in 2023 due to advanced veterinary healthcare infrastructure, high pet ownership, and strong presence of key players. However, Asia-Pacific is projected to experience the fastest growth, driven by increasing demand for animal protein, rising awareness of veterinary care, and government-led animal health programs.

Competitive Scenario:

Key players in the global veterinary products market include Zoetis Inc., Elanco Animal Health, Merck Animal Health, Boehringer Ingelheim, Virbac, Vetoquinol, Ceva Santé Animale, Dechra Pharmaceuticals, Bayer AG, and Norbrook Laboratories. These companies are focusing on strategic collaborations, geographic expansion, and product innovation to maintain their market positions.

Key Developments:

In 2023, Zoetis launched a next-generation parasiticide for dogs, offering broader protection with fewer side effects.

Elanco acquired a regional vaccine manufacturer in 2024 to expand its livestock portfolio in Southeast Asia.

Virbac introduced an oral vaccine for swine diseases in 2025, facilitating easier administration and compliance.

Scope of Work – Global Veterinary Products Market

FAQs:

1) What is the current market size of the Global Veterinary Products Market?

The market size was valued at USD 45.6 billion in 2023.

2) What is the major growth driver of the Global Veterinary Products Market?

The major growth drivers include rising pet adoption, increasing demand for animal-derived food products, and advances in veterinary medicine.

3) Which is the largest region during the forecast period in the Global Veterinary Products Market?

North America held the largest market share in 2023, but Asia-Pacific is expected to grow at the fastest rate.

4) Which segment accounted for the largest market share in the Global Veterinary Products Market?

The Pharmaceuticals segment accounted for the largest market share in 2023.

5) Who are the key market players in the Global Veterinary Products Market?

Key players include Zoetis Inc., Elanco Animal Health, Merck Animal Health, Boehringer Ingelheim, and Virbac.